EURetina 2019 Congress
Sep 5 - Sep 8, 2019
Thursday, September 5, 2019
11:59am CEST
Presentation by Pravin U. Dugel, MD
Session: Novelties and Late Breaking Developments in Retina & Technology
Title: Novel anti-VEGF antibody biopolymer conjugate KSI-301 with potential for extended durability in retinal vascular diseases: first-time results from a phase 1b study in patients with wAMD, DME and RVO
Sunday, September 8, 2019
9:48am CEST
Presentation by Pravin U. Dugel, MD
Free Paper Session
Title: Extended durability in exudative retinal diseases using a new class of molecules: novel anti-VEGF antibody biopolymer conjugate KSI-301: first-time results of the phase 1b study in patients with wAMD, DME and RVO
Supporting Materials
Location
Paris, France